BACIT LIMITED
(a closed-ended investment company incorporated in Guernsey
with registration number 55514)
(the "Company")
25 November 2014
Notice of Extraordinary General Meeting to approve amendment to investment
policy to facilitate investment in CRT Pioneer Fund LP
A Circular, including a notice of an extraordinary general meeting of the
Company to be held at 3 p.m. on 15 December 2014 regarding an amendment to the
Company's investment policy (the "Investment Policy") to facilitate a proposed
investment in CRT Pioneer Fund LP (the "Pioneer Fund"),is being sent to
shareholders today.
The Pioneer Fund is an English limited partnership, managed by Sixth Element
Capital LLP ("Sixth Element"). The Pioneer Fund's investment policy is to
invest in projects and intellectual property assets with a life science or
medical technologies focus related to oncology, including therapeutics and
diagnostics. Through these investments the Pioneer Fund aims to enable the
commercialization of innovative scientific research or prototypes arising
primarily but not exclusively from the network of research centres, research
groups or individual researchers associated with Cancer Research UK for the
benefit of cancer patients globally.
The Company's Investment Policy currently permits it to invest up to one per
cent. per annum of the Company's net asset value to acquire interests in drug
development and medical innovation projects undertaken by the Institute of
Cancer Research or its subsidiaries in the field of cancer research and
therapeutics which have the potential for commercial development and
application ("ICR Projects"). The Company now has an opportunity to invest in
the Pioneer Fund which will allow it to benefit from the expertise of Sixth
Element in investments relevant to this part of its Investment Policy. Payments
to the Pioneer Fund will be counted as investments in ICR Projects for the
purpose of the one per cent. of net asset value limit on amounts that may be
invested annually in ICR Projects. It is possible, but unlikely, that in any
one year (and after taking account of any uninvested amounts carried over from
previous years) payments to the Pioneer Fund may be required to exceed this
limit.Unlike the Company's other investments, the investment in the Pioneer
Fund would not be made on a "fee free" basis.
As the proposed investment into the Pioneer Fund and the terms on which it
would be made do not fall precisely within the Investment Policy, shareholders
are being asked to approve an amendment to the Investment Policy to permit the
Group's investment in the Pioneer Fund as set out in more detail in the
Circular.
A copy of the Circular will shortly be available on the Company's website at
http://www.bacitltd.com . The Circular has also been submitted to the National
Storage Mechanism and will shortly be available for inspection at
www.morningstar.co.uk/uk/nsm .
Enquiries:
Northern Trust International Fund Administration Services (Guernsey) Limited
Tel: +44 (0) 1481 745368
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.